Exact Sciences Corp
NASDAQ:EXAS

Watchlist Manager
Exact Sciences Corp Logo
Exact Sciences Corp
NASDAQ:EXAS
Watchlist
Price: 55.31 USD 3.31% Market Closed
Market Cap: 10.4B USD
Have any thoughts about
Exact Sciences Corp?
Write Note

Wall Street
Price Targets

EXAS Price Targets Summary
Exact Sciences Corp

Wall Street analysts forecast EXAS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EXAS is 70.72 USD with a low forecast of 54.54 USD and a high forecast of 94.5 USD.

Lowest
Price Target
54.54 USD
1% Downside
Average
Price Target
70.72 USD
28% Upside
Highest
Price Target
94.5 USD
71% Upside
Exact Sciences Corp Competitors:
Price Targets
300294
China Resources Boya Bio pharmaceutical Group Co Ltd
30% Upside
6955
Shandong Boan Biotechnology Co Ltd
26% Downside
005690
Pharmicell Co Ltd
37% Upside
BCYC
Bicycle Therapeutics PLC
239% Upside
688373
Shanghai MicuRx Pharmaceutical Co Ltd
22% Downside
301207
Hualan Biological Bacterin Inc
16% Upside
ORKA
Oruka Therapeutics Inc
188% Upside
068270
Celltrion Inc
25% Upside

Revenue
Forecast

Revenue Estimate
Exact Sciences Corp

For the last 8 years the compound annual growth rate for Exact Sciences Corp's revenue is 52%. The projected CAGR for the next 3 years is 13%.

52%
Past Growth
13%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Exact Sciences Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

Net Income Estimate
Exact Sciences Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-22%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is EXAS's stock price target?
Price Target
70.72 USD

According to Wall Street analysts, the average 1-year price target for EXAS is 70.72 USD with a low forecast of 54.54 USD and a high forecast of 94.5 USD.

What is Exact Sciences Corp's Revenue forecast?
Projected CAGR
13%

For the last 8 years the compound annual growth rate for Exact Sciences Corp's revenue is 52%. The projected CAGR for the next 3 years is 13%.

Back to Top